VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_17-vv-01369
Package ID: USCOURTS-cofc-1_17-vv-01369
Petitioner: Charles Gensmer
Filed: 2020-07-22
Decided: 2020-08-17
Vaccine: influenza
Vaccination date: 2014-09-29
Condition: Guillain-Barre Syndrome (GBS)
Outcome: compensated
Award amount USD: 30500

AI-assisted case summary:
Charles Gensmer filed a petition for compensation under the National Vaccine Injury Compensation Program on July 22, 2020, alleging that he suffered from Guillain-Barre Syndrome (GBS) as a result of his flu vaccination administered on September 29, 2014. The respondent denied that petitioner sustained a Table GBS injury or any injury as a result of the vaccine. Despite the respondent's denial, the parties filed a joint stipulation on damages. Special Master Daniel T. Horner reviewed the stipulation and found it reasonable. The court awarded Charles Gensmer $30,500.00 as compensation for all items of damages, to be paid in a lump sum via check. Petitioner's counsel was Kate G. Westad of Sieben Carey, and respondent's counsel was Alexis B. Babcock of the U.S. Department of Justice. The decision was issued on August 17, 2020.

Theory of causation field:
Petitioner Charles Gensmer alleged that his September 29, 2014, influenza vaccination caused Guillain-Barre Syndrome (GBS). Respondent denied that petitioner sustained a Table GBS injury or any injury as a result of the vaccine. The public decision does not describe the specific theory of causation, medical experts, clinical details of the GBS onset or progression, or any specific diagnostic tests or treatments. The parties filed a joint stipulation on damages, which Special Master Daniel T. Horner found reasonable. An award of $30,500.00 was made as a lump sum. The decision date was August 17, 2020. Petitioner's counsel was Kate G. Westad, and respondent's counsel was Alexis B. Babcock.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_17-vv-01369-0
Date issued/filed: 2020-08-17
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 7/22/2020) regarding 45 DECISION Stipulation/Proffer. Signed by Special Master Daniel T. Horner. (et) Service on parties made.
--------------------------------------------------------------------------------
Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 17-1369V
Filed: July 22, 2020
UNPUBLISHED
CHARLES GENSMER,
Petitioner,
Joint Stipulation on Damages;
v.
Influenza (Flu) Vaccine; Guillain-
Barre Syndrome (GBS)
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Kate G. Westad, Sieben Carey, Minneapolis, MN,, for petitioner.
Alexis B. Babcock, U.S. Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
On September 27, 2020, petitioner filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the
“Vaccine Act”). Petitioner alleges that he suffered from Guillain-Barre Syndrome
(“GBS”) as a result of his September 29, 2014 flu vaccination. Petition at ¶1;
Stipulation, filed July 22, 2020, at ¶¶ 1-4. Petitioner further alleges that there has been
no prior award or settlement of a civil action for damages as a result of his condition.
Petition at ¶7; Stipulation at ¶ 5. “Respondent denies that petitioner sustained a Table
GBS injury, and denies that petitioner suffered any injury as a result of the influenza
vaccine administered on or about September 29, 2014.” Stipulation at ¶ 6.
Nevertheless, on July 22, 2020, the parties filed the attached joint stipulation,
stating that a decision should be entered awarding compensation. I find the stipulation
reasonable and adopt it as the decision of the Court in awarding damages, on the terms
set forth therein.
1 Because this decision contains a reasoned explanation for the special master’s action in this case, it will
be posted on the United States Court of Federal Claims’ website in accordance with the E-Government
Act of 2002. See 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic
Government Services). This means the decision will be available to anyone with access to the
Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact
medical or other information the disclosure of which would constitute an unwarranted invasion of privacy.
If the special master, upon review, agrees that the identified material fits within this definition, it will be
redacted from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 2 of 7
Pursuant to the terms stated in the attached Stipulation, I award the following
compensation:
A lump sum of $30,500.00 in the form of a check payable to petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under § 15(a). Id.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the
clerk of the court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Daniel T. Horner
Daniel T. Horner
Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 3 of 7

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 4 of 7

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 5 of 7

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 6 of 7

Case 1:17-vv-01369-UNJ Document 49 Filed 08/17/20 Page 7 of 7